Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 14/20 | 0.55 |
| ▸ | WNT3A | P56704 | 2/20 | 0.52 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.51 |
| ▸ | GSK3B | P49841 | 2/20 | 0.49 |
| ▸ | CDK1 | P06493 | 1/20 | 0.48 |
| ▸ | CDK4 | P11802 | 1/20 | 0.48 |
| ▸ | CDK2 | P24941 | 1/20 | 0.48 |
| ▸ | JAK2 | O60674 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ABL1 | P00519 | 1/20 | 0.44 |
| ▸ | BCR | P11274 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31240675 | 0.92 | WNT3A (0.52) | MAPK14WNT3ACSNK1DCDK1CDK4 | |
| SCHEMBL31240349 | 0.90 | WNT3A (0.50) | MAPK14WNT3ACDK1CDK4CDK2 | |
| SCHEMBL31240714 | 0.90 | WNT3A (0.55) | MAPK14WNT3ACSNK1DCDK1CDK4 | |
| SCHEMBL31240493 | 0.90 | WNT3A (0.57) | MAPK14WNT3AGSK3BCDK1CDK4 | |
| SCHEMBL31240509 | 0.90 | JAK2 (0.56) | MAPK14WNT3AGSK3BCDK1CDK4 | |
| SCHEMBL31240382 | 0.89 | MAPK1 (0.52) | MAPK14WNT3AGSK3BCDK1CDK4 | |
| SCHEMBL31240404 | 0.89 | MAPK14 (0.52) | MAPK14WNT3AGSK3BCDK1CDK4 | |
| SCHEMBL31240457 | 0.87 | WNT3A (0.50) | MAPK14WNT3AGSK3BCDK1CDK4 | |
| SCHEMBL31240322 | 0.87 | MAPK10 (0.58) | WNT3ACDK2MEN1RAB9AKMT2A | |
| SCHEMBL31240436 | 0.86 | WNT3A (0.47) | MAPK14WNT3ACSNK1DCDK1CDK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | claimed |
| WO-2024228035-A1 | IKK-ALPHA INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-11-07 | — | — | WO | claimed |
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024228035-A1 | IKK-ALPHA INHIBITORS | CANCER RESEARCH TECHNOLOGY LIMITED (GB) | 2024-11-07 | — | — | WO | disclosed |